Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology
- 27 November 2000
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (7) , 2204-2211
- https://doi.org/10.1016/s0735-1097(00)00994-3
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Long-term therapy for pulmonary hypertension in childrenCurrent Opinion in Pediatrics, 1999
- Low‐dose inhaled nitric oxide for neonates with pulmonary hypertensionJournal of Paediatrics and Child Health, 1996
- Effects of inhaled nitric oxide in rats with chemically induced pulmonary hypertensionRespiration Physiology, 1994
- Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertensionCritical Care Medicine, 1994
- Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose responseThe Journal of Pediatrics, 1994
- Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxideThe Journal of Pediatrics, 1993
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993
- The effect of the calcium antagonist, isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double-blind, placebo-controlled studyJournal of Internal Medicine, 1991
- EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MANThe Lancet, 1989
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980